Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 6,038 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Obesity, Diabetes, Nutrition, Physical Health
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 12 Years to 17 Years
Enrollment: 214 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Milwaukee and Madison, Wisconsin

Conditions: Hyperglycemia
Interventions: High-Intensity Functional Training, Aerobic and Resistance Training; Other
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Binge Eating Disorder Associated With Obesity
Interventions: Zonegran, sugar pill; Drug
Lead sponsor: Lindner Center of HOPE; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Metabolic Syndrome X
Interventions: Eplerenone, Ramipril; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ultra-Processed Food Intake, Obesity & Overweight
Interventions: Introductory Educational Workshop, Standard Dietary Change (ON/OFF), Cognitive Dissonance Strategies (ON/OFF); Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Springfield, Oregon

Conditions: Obesity
Interventions: Craving and Lifestyle Management through Mindfulness(CALMM+); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity
Interventions: IncentaHealth; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: David City, Nebraska

Conditions: Insulin Resistance, Obesity
Interventions: INCB13739; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Beverly Hills, California • Chula Vista, California

Conditions: Obesity, Healthy Volunteers
Interventions: S309309, Itraconazole; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: NNC0174-0833, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 22 Years to 64 Years · Male only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Obesity, Childhood
Interventions: CCC, Enhanced Usual Care; Behavioral
Lead sponsor: American University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Breast Cancer, Obesity
Interventions: aerobic exercise; Behavioral
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Type 2 Diabetes
Interventions: Januvia (Sitagliptin) 100 mg, Placebo; Drug
Lead sponsor: University at Buffalo; Other
Eligibility: 20 Years to 75 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Loss-of-Control Eating, Obesity/Overweight
Interventions: Naltrexone and Bupropion (NB) medication, Placebo; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obesity, Overweight
Interventions: Tirzepatide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 40 Years and older
Enrollment: 15,374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 165
States / cities: Gilbert, Arizona • Mesa, Arizona • Phoenix, Arizona + 141 more

Conditions: Obesity, Overweight
Interventions: Behavioral Weight loss; Behavioral
Lead sponsor: California Polytechnic State University-San Luis Obispo; Other
Eligibility: 30 Years to 45 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Luis Obispo, California

Conditions: Type 2 Diabetes
Interventions: Not listed
Lead sponsor: Kaiser Permanente; Other
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 1,035 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2030
U.S. locations: 1
States / cities: Oakland, California

Conditions: Aging
Interventions: Caloric restriction; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 25 Years to 46 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Obesity
Interventions: Enhanced Care; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Weight Loss
Interventions: VK2735; Drug
Lead sponsor: Viking Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 4,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 135
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 119 more

Conditions: Obesity, Obesity, Morbid, Pregnancy, Infection; Cesarean Section
Interventions: Cefazolin; Drug
Lead sponsor: MemorialCare Health System; Other
Eligibility: Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Long Beach, California • Orange, California

Conditions: Binge Eating Disorder
Interventions: Postprandial responses, Cold pressor test, Test meal; Procedure · Behavioral
Lead sponsor: New York Obesity and Nutrition Research Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Acquired Hypogonadotropic Hypogonadism, Obesity
Interventions: Placebo, Enclomiphene; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 5
States / cities: Albany, New York • Garden City, New York • Providence, Rhode Island + 2 more

Conditions: Obesity, Diabetes, Hypertension, Hyperlipidemia
Interventions: Exercise, Reduced Calorie Diet, Weight Maintenance Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 65 Years and older
Enrollment: 167 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Effects of Environmental Opportunities and Barriers on Physical Activity, Fitness, and Health in Hispanic Children in Wisconsin

CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults

Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity

Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

Dietary Interventions to Reduce Ultra-Processed Food Intake

Craving and Lifestyle Management Through Mindfulness Pilot Study

Examining Reach and Implementation of an Evidence-based Weight Loss Program in Rural Primary Care

A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants

Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects

Reducing Maternal Stress to Improve Obesity-related Parenting Practices

Effect of Diet and Exercise in Breast Cancer Survivors

The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Choose to Lose for Women-Weight Loss to Reduce Breast Cancer Risk Factors

SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy

CALERIE Phase II Ancillary: Metabolic

Teaching Appropriate Gestational Weight Gain

VK2735 for Weight Management Phase 3

Increased Cefazolin During Cesarean Delivery in Obese Population

Appetite Hormones in Binge Eating Disorder

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults